Als

Treg cell therapy showing promise in ALS trials: Coya Therapeutics

02-Aug-2021 By Jenni Spinner

According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.

Medidata in deal on AI biomarker identification for ALS developments

09-Mar-2020 By Vassia Barba

Project ALS has selected Medidata’s biomarker discovery solution for its research projects, aiming to improve understanding of the ALS disease process and develop new therapeutic strategies.

Biohaven’s application rejected due to Apotex manufacturing issues

22-Jul-2019 By Ben Hargreaves

Biohaven’s sublingual Riluzole treatment for ALS receives a CRL from the US FDA due to the API being supplied by Apotex.

Aquestive’s oral film ALS medication approved by FDA

23-Apr-2019 By Maggie Lynch

US FDA approves Aquestive’s oral film medication for the treatment of ALS using its PharmFilm technology.

Spotlight

(Panuwat Sikham/iStock via Getty Images Plus)

‘Progress does not happen overnight’: Sanofi on evolution of medicine

(Riccardo Lennart Niels Mayer/iStock via Getty Images Plus)

ViiV submits FDA application for pediatric HIV treatment

(smartboy10/iStock via Getty Images Plus)

CDC turns to PointClickCare to gain insights from patient data

(FatCamera/iStock via Getty Images Plus)

Increasing trial diversity ‘top of mind’ for Lilly Oncology

(elenabs/iStock via Getty Images Plus)

Medable launches Site Network Council to elevate decentralized trials

Follow us

Products

View more

Webinars

Upcoming editorial webinars

17 Nov 2021 Wed Webinar Patient-centric Solutions

On-demand webinars

Featured Suppliers

All suppliers

Ajinomoto Bio-Pharma Services

Baxter BioPharma Solutions

BioContinuum™ Platform - MilliporeSigma

Covance Patient Safety

Frontage Laboratories

Laurus Labs Ltd.

Piramal Pharma Solutions

PRA Health Sciences

Precision for Medicine

Softigel by Procaps

Vetter Pharma International GmbH